Tokyo, Japan

Maiko Sakamoto

This inventor holds 1 USPTO granted patent. Top assignee: Ribomic Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maiko Sakamoto. Retrieved from https://idiyas.com/inventor/maiko-sakamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maiko Sakamoto: Innovator in Aptamer Technology

Introduction

Maiko Sakamoto is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of aptamers. Her innovative work has the potential to impact various medical applications.

Latest Patents

Maiko Sakamoto holds a patent for an "Aptamer to FGF2 and use thereof." This patent includes an aptamer that exhibits inhibitory activity on FGF2. It also describes a complex that contains the aptamer along with a functional substance, such as an affinity substance, labeling substance, enzyme, drug delivery vehicle, or drug. Additionally, the patent covers a medicament, diagnostic reagent, or label that incorporates the aptamer or the complex.

Career Highlights

Maiko is currently associated with Ribomic Inc., where she continues to advance her research and development efforts. Her work is recognized for its potential to enhance therapeutic strategies and diagnostic tools in medicine.

Collaborations

Maiko collaborates with notable colleagues, including Yoshikazu Nakamura and Akira Ishiguro. These partnerships contribute to the innovative environment at Ribomic Inc. and foster advancements in their respective fields.

Conclusion

Maiko Sakamoto is a trailblazer in aptamer technology, with her patent showcasing her innovative spirit and dedication to improving medical science. Her contributions are paving the way for future advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…